ESRT vs REGN · P/E 27, rev $766.8M vs P/E 14, rev $14.34B
Empire State Realty Trust Inc (ESRT) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Empire State Realty Trust Inc (ESRT) is a reit - diversified company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported ESRT revenue for 2024-12-31 was $766.8M. Net income was $80.4M. Revenue was up 3.9% from 2023-12-31 to 2024-12-31. ESRT currently screens at market cap $2.40B and trailing P/E 27.0.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
ESRT currently screens at market cap $2.40B and trailing P/E 27.0. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the ESRT and REGN stock pages for the full models.
Not investment advice.